Cancer's Latency Could Drive Zantac Cancer Claims For Years
An FDA statement on the levels of a carcinogen found in Zantac may necessitate that no other conclusion
Monday, July 20, 2020 - Scientists are asking a billion-dollar question of whether or not ordinary, everyday individuals like you and I may have developed cancer from taking the drug Zantac and not presently know about it. Zantac cancers such as cancer of the stomach have a latency period of up to 22 years, as reported by a study into cancer latency times by Hindawi.com. A large percentage of these cancers could have been caused by using Zantac regularly over the years to alleviate simple heartburn or acid reflux. It appears that there is little doubt that Zantac causes cancer. Science World Report wrote on the subject of American's ticking Zantac timebomb telling readers, "In September 2019, the Food and Drug Administration (FDA) announced that the drug Zantac contained high amounts of the cancer-causing chemical N-nitrosodimethylamine (NDMA)," and that "The FDA found that Zantac contained 3,000-26,000 times the officially recommended dosage of NDMA. Therefore, Zantac can cause cancer."
Experts may be switching away from trying to figure out whether or not Zantac users may have developed cancer, but instead, focus on the extent of the problem. Cancer is the second leading cause of death in the United States. Approximately 13 million Americans could be walking around with the disease and not know it. No one knows for sure at this time how Zantac's NDMA problem got started, however, it may be to be due to storing the drug at high temperatures, the drug's interaction with nitrates in the stomach, and/or contamination during the overseas manufacturing process. Thousands of cancer-sufferers or the estates of those who have died from Zantac cancer are adding their cases to class action lawsuits or suing Sanofi outright for failing to tell consumers what they knew or had the responsibility to know about Zantac's deadly side effect.
If you or a loved one have taken Zantac regularly and have developed cancer you should consult with a Zantac Cancer Lawyer immediately and see if you qualify to file a claim. Plaintiffs to date are alleging that taking Zantac caused them to develop cancer of the stomach, bladder, esophagus, liver, pancreas, prostate, breast, colon, and other forms of the deadly disease. How many billions of dollars in profits have Sanofi and other companies pocketed in the last 20 years from selling a product that could have been causing cancer from day one? One estimate is that over 15 million Americans were taking Zantac at the time of the drug's FDA recall earlier this year. The directors of Sanofi could be exposed to criminal charges as well when investigators answer the question, "What did Sanofi executives know about Zantac cancer and when did they know it?"
As of developing cancer was not enough, taking Zantac could also have other detrimental effects. Zantac and other drugs block the production of stomach acids that are essential to fight off infection and viruses. Some think that using H2 histamine blockers of protein pump inhibitor drugs like Zantac or Prilosec could make one more susceptible to the Coronavirus and make the virus's symptoms more severe, even deadly.
More Recent Heartburn MedicineLawsuit News:
- Zantac Cancer Trials Are In Discovery To Begin In October 2022 | 7/19/2022
- Zantac Cancer Lawsuits Could Hinge On The Validity of Ranitidine Testing Methods | 7/11/2022
- Zantac Cancer Bellwether Trials In California Could Set The Stage For A Global Settlement Offer | 7/5/2022
- The FDA Recommended Protein Pump Inhibitor Drugs Like Prilosec And Nexium That May Damage Health More Than Zantac | 6/23/2022
- Truck Drivers, Firefighters, and Police Officers May Have Taken More Zantac Than People In Other Occupations | 6/20/2022
- Scientists Are Expected To Confirm That Ranidine Causes Gastrointestinal Cancer With Slam Dunk Testimony | 6/9/2022
- Scientific Hearings Will Start This September To Interview Zantac Cancer Expert Witnesses | 5/19/2022
- A Whistleblower Scientist Working For A Chinese Company Thinks NDMA Contamination Started In China | 5/12/2022
- Valisure's String Of Stunning Success Casts Doubt On The FDAs Ability To Police The Health Care Market | 5/2/2022
- Zantac Testing Accusations Heat Up With FDA Investigation Of Online Prescription Drug Testing Lab | 4/25/2022
- Study Finds Ranitidine Degrades Into 10,000 Nanograms of NDMA When Introduced To Simulated Stomach Conditions | 4/6/2022
- Potential Zantac Expert Witnesses Are Being Questioned By Zantac Defense Attorneys | 3/31/2022
- The FDA Requires That Drug Companies Regularly Test Ranitidine And Other Drug For NDMA | 3/24/2022
- Update: Where The Zantac Cancer Multidistrict Litigation (MDL) Stands Today | 3/12/2022
- Zantac Cancer Plaintiffs Look To The First Trial In October In Alameda California | 3/11/2022
- Zantac Cancer Plaintiffs Have Until June 30 To Finalize Their Claim | 3/7/2022
- Zantac Bellwether Trials May Focus On Ranitidine Testing Methods That Could Cause NDMA To Accelerate | 3/1/2022
- Valisure LLC's Motivations And Ranitidine Testing Methods May Not Be Scrutinized Before Trial | 2/24/2022
- Zantac Lawsuits May Go To Trial In California In October Of This Year | 2/18/2022
- Sanofi's History Of Reprehensible Corporate Behavior May Bolster Zantac Cancer Lawsuits | 2/10/2022
Lawyers for Zantac Heartburn Medicine Lawsuits
OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.